In 2023, NASA Langley's workforce brought imagination to reality with innovative technological development and a continued commitment to tackling some of the tough challenges that both NASA and the ...

OSAKA, Japan, Jan. 28, 2025 /PRNewswire/ -- Sekisui House, Ltd. extends its deepest condolences to the families who have lost loved ones in the ongoing wildfires in Los Angeles and offers ...

BeyondSpring (BYSI) has entered into definitive agreements to sell a portion of its Series A-1 Preferred Shares of SEED Therapeutics for gross proceeds of approximately $35.4M. Upon completion of ...

DALLAS, April 1, 2022 /PRNewswire/ -- Sekisui Specialty Chemicals, provider of multiple chemical solutions, is excited to announce the launch of its new website, www.Advancell.com. Advancell ...

A biotech company developing novel T cell therapies to achieve long-term remission in patients with advanced solid cancers. The company was founded by Professor John Campbell, a renowned T cell ...

1 Day SKSUF 11.00% DJIA 0.65% S&P 500 -1.46% Real Estate/Construction -1.18% ...

A 6.5-month-old boy with the rare inherited urea cycle disorder ornithine transcarbamylase (OTC) deficiency has responded positively in a targeted in vivo gene editing trial, in which a correct copy ...

The Speaker of the House of Representatives, the Honourable Milton Dick MP has received letters of resignation from the Honourable Bill Shorten and the Honourable Keith Pitt. The Speaker is now ...

Malaria remains a significant global health challenge, causing over 600,000 deaths annually despite existing prevention and treatment measures. Current vaccines and monoclonal antibodies (mAbs) ...

Omeros Corporation today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings ...